$NVAX 2 days after calling out US/FDA for being in bed with Phizer, VRBPAC member Meissner responds by saying he is 'excited' by prospect of Nuvaxovid in US:
https://t.co/eFo2mxpLCj
Novavax announced their vaccine protects adolescents from Delta infection by 80% (95% CI, 47-92%) after dose 2 vs placebo. Side effects were stated as similar or milder than adults.
Short thread to put in context
https://t.co/pQIWFgfrSj
BREAKING: Novavax says COVID-19 vaccine is 82% effective* in adolescents (12-17 yo); company will file EUA in Q1.
*Mostly against Delta (trial ended before Omicron)
-No update on FDA filing for 18+
-Blames delays of EU shipments on local testing rules @ distribution sites
$NVAX
Spain to use #Novavax for boosters in previously vaccinated with mRNA. More countries on the cusp of approving the same as they realize mRNA boosters don’t prevent Omi transmission. $NVAX is also ahead in the #MultiValent game. Science cannot be ignored. https://t.co/2lbVaAD7rd
“We're beginning to see a lot of demand in European countries for Novavax vaccine, which is sometimes used for boosters. It’s been a very effective booster. “
$nvax
Seth Berkley’s tall order - POLITICO https://t.co/DpH0BzhA9p
$NVAX production line for 2022 looks quite appealing if you consider it’s current market cap of 10.82B 😳 No brainier why JP Morgan have gone long as this can easily reach $450 on the back of its pipeline that is insane 🔥🚀🔥